Skip to content

Clinical efficacy analysis of total laparoscopic liver transplantation

Clinical efficacy analysis of total laparoscopic liver transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123197
Enrollment
Unknown
Registered
2026-04-22
Start date
2025-05-01
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary liver cancer, liver cirrhosis, liver failure

Interventions

liver transplantation:None

Sponsors

Zhongshan People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Voluntarily sign the informed consent form; 2.Patients who underwent liver transplantation at our hospital from December 2022 to March 2025; 3.Recipient age: 18–65 years; 4.Underwent liver transplantation for the first time; 5.The transplant came from a brain-dead donor; 6.Whole Liver Transplant; 7.Baseline Model for End-Stage Liver Disease (MELD) score < 24; 8.No history of major upper abdominal surgery;

Exclusion criteria

Exclusion criteria: 1.Patients with missing data or who were not visited;

Design outcomes

Primary

MeasureTime frame
Postoperative complications;Postoperative liver function;

Countries

China

Contacts

Public ContactSun Qiang

Zhongshan People’s Hospital

sqchina@163.com+86 760 8988 0300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026